Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT00057863Phase 2Completed
Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical Cancer
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma+3 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Bradley Monk

Gynecologic Oncology Group

Related
2 trials

Shared therapeutic areas:

Cervical Squamous Cell CarcinomaCervical AdenocarcinomaCervical Adenosquamous Carcinoma+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score25%

Peter Rose

Gynecologic Oncology Group

Related
2 trials

Shared therapeutic areas:

Cervical AdenocarcinomaCervical Squamous Cell CarcinomaStage IVA Cervical Cancer+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

D. McMeekin

Gynecologic Oncology Group

Related
4 trials

Shared therapeutic areas:

Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

Mitesh Borad

Mayo Clinic

Related
2 trials

Shared therapeutic areas:

Cervical Squamous Cell CarcinomaRecurrent Cervical CarcinomaStage IVA Cervical Cancer+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

John K Chan

NRG Oncology

Related
3 trials

Shared therapeutic areas:

Cervical AdenocarcinomaCervical Adenosquamous CarcinomaRecurrent Cervical Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Matthew S. Block, M.D., Ph.D.

Mayo Clinic in Rochester

Related
2 trials

Shared therapeutic areas:

Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma
Similarity Score15%

Alessandro D Santin

NRG Oncology

Related
2 trials

Shared therapeutic areas:

Cervical AdenocarcinomaCervical Adenosquamous CarcinomaRecurrent Cervical Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Jyoti S Mayadev

NRG Oncology

Related
3 trials

Shared therapeutic areas:

Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Allan L Covens

NRG Oncology

Related
2 trials

Shared therapeutic areas:

Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Jorge Oldan, MD

University of North Carolina, Chapel Hill

Related
4 trials

Shared therapeutic areas:

Cervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT00057863Phase 2PrincipalInvestigator

Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical Cancer

Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma+3 more
Completed

All 1 trials loaded